About Natera

About Natera

Natera is a rapidly-growing diagnostics company with proprietary bioinformatics and molecular technology for analyzing DNA. Natera’s complex technology has been proven clinically and commercially in the prenatal testing space and the Company is actively researching its applications in the liquid biopsy space for developing products with oncology applications.

Since 2009, Natera has launched seven molecular diagnostic tests, many of which are available through major health plans accounting for more than 140 million covered lives in the United States. The Company’s own robust laboratory processes thousands of genetic tests per month.

Natera’s goal is to transform the way people – both providers and patients – respond to and manage genetic diseases.

Learn More About Natera

Stock Information

NTRA (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$19.75
Change (%) Stock is Up 0.35 (0.00%)
Volume580,989
Data as of 03/18/19 4:00 p.m. ET
Minimum 15 minute delay
Refresh quote
Stock chart for: NTRA.O.  Currently trading at $19.75 with a 52 week high of $29.62 and a 52 week low of $8.60.

Recent News

Natera Reports Fourth Quarter and Fiscal Year 2018 Financial Results - 03/12/19
SAN CARLOS, Calif., March 12, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial results for the fourth quarter and year ended December 31... More»
Natera and BGI Genomics Announce $50M Partnership to Commercialize Signatera Oncology Test in China and to Develop Reproductive Health Tests in Select Markets on BGI's DNBseq™ Technology Platform - 03/11/19
Partnership marks significant milestone for Natera in monetizing its Signatera MRD test and for BGI Genomics a strong endorsement of its DNBseq™ technology platform by a leader in cell-free DNA genetic testing SAN CARLOS, Calif. and SHENZHEN, Ch... More»
/C O R R E C T I O N -- Natera, Inc./ - 03/06/19
In the news release, Natera, Inc. Announces Fourth Quarter and Fiscal 2018 Earnings Conference Call, issued 05-Mar-2019 by Natera, Inc. over PR Newswire, we are advised by the company that the first paragraph, last sentence, as well as the 'Earnings ... More»
Natera, Inc. Announces Fourth Quarter and Fiscal 2018 Earnings Conference Call - 03/05/19
Natera Also to Present at 39th Annual Cowen Healthcare Conference SAN CARLOS, Calif., March 5, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA, today announced that it will release results for its fourth quarter and y... More»
Natera Announces Publication of Analytical Validation Study Demonstrating Superior Precision of Its Kidney Transplant Rejection Assay - 02/22/19
Core Technology Delivers Superior Analytical Performance, Underpins Outstanding Clinical Performance SAN CARLOS, Calif., Feb. 22, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA, today announced analytical validation ... More»

Upcoming Events

Webcast
Natera, Inc. Q4 2018 Earnings Conference Call (Replay)
03/12/19 at 4:30 p.m. ET
Natera, Inc. Q4 2018 Earnings Conference Call
Tuesday, March 12, 2019 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
There are currently no events scheduled.
Shareholder Tools